- General-purpose how-tos, guides, and topical collaboratives: Corona Handbook
- Some active dashboards: /Dashboards
See also: [WD, WP, WS, Commons], endcoronavirus, [https://charleseisenstein.org/essays/the-coronation/ coro-essay]
- The New Possible - reflections on positive changes now possible around the world [takes suggestions]
- Use AirDroid to develop mobile interfaces
Tools in development/use
- Covid-Obit - to help file obits for people who died of COVID. (Vera)
- Spreadsheet tool - using a programmed Google Sheet to generate json to update a .tab file on Commons
Related tickets and requests
- Main article and its translations
- Misinformation explosion and articles dedicated to it (active on EN, deleted in ML)
- One specifically on health disinfo; one on inflammatory/racist info
- Drug research and implications
- Other derivatives: disease surveillance
- Little info on affect on different ages, professions, race/ethnicity [N wants to work on them]
- Art and animations: N nags her partner to make them :)
- Some come from NIH and others.
- Some are generated from data
- Videos are mainly of white men performing procedures... few from E.Asia or the south
- Many people are watching related articles to find information as it's inserted.
Italy has a shortage of test kits. Recently 50k were provided by China.
The US has a shortage of test facilities, and needs local university and hospital labs to speed up testing.
- The CDC is doing almost no direct tests. They aggregate data with minimal transparency and are often out of date. Modelers may need to get data directly from states. :
- States have capacity, but have been told not to test, or restricted in who they could 'officially' test. They need to ignore those restrictions
- Universities and local hospitals have potential capacity, and need to upgrade facilities and focus them on coronavirus. Ex: UW Virology Lab, Brigham + Women's Hospital
- Anyone with a Roche cobas machine should convert its use to covid testing.
- Quest + LabCorp promised to spin up testing this week but have no staff to do so -- possibly for lack of funding... ? Ensure they have new hires asap. (AB)
Reagents and kits
- For swab tests, nylon swabs and test tubes are in short supply as of March 11.
- For blood tests, reagents aren't in short supply but they aren't currently widely used in the US. (AB)
- For full kits, Qiagen has been providing reagents and test kits at scale on request, and needs steady + predictable demand. (they were acquired last week by Thermo Fisher).
Coordinated data + dashboard
- Microsoft BI, Arcgis, and Tableau should all have solutions for
- making Covid data more accessible across instances (ways to find related layers / sources, as you build a new one)
- making data more accessible to viewers (options to export/download raw daa, when you encounter one online)
- We need a global dashboard as good as this; and a national one for each country.
- I have found 5 different dashboards/ counters through google over a couple of weeks:
United States data
- I find they are all excellent but none provide me with all the information I need. Ottawahitech (talk) 02:30, 28 March 2020 (UTC)
- Data protocols: everyone needs to improve this, for replicable + verifiable data. Example: covidtracking
- Doc sharing: aggregated notes + documents.
Rough aggregate data: Plague.com , HealthMap
Specific local models: China, Singapore, Korea, Taiwan, Vietnam
Data only: covidtracking.com (US)
Models of spread
Good local modeling requires tracking of individual patients. Line lists of patients, infected and monitored, and careful tracing of their contacts, is essential for this. In countries where that is available, local models can predict outcomes. While such lists are rarely available in real-time to the public, but in pandemics that is the only efficient way to proceed.
- Global: HealthMap
- China: Early analysis supported by grassroots doctors networks, while the government was limiting public visibility into the outbreak. Some results: Open Access Epidemiological Data from COVID-19
Example city models:
Checklists; protocols -- documents by country (classified and grouped)
One instance of a virtual test underway of preventive drug efficacy (via AB):
- A drug is already in use in many countries, can be used quickly; requires raw materials from China.
- 2-wk controlled experiment: run on people in households w/a known infected person -- see if this reduces likelihood or severity of getting it themselves. Needs 2000 participants in a randomly controlled trial.
- Replicating doctor-maintained workflows to track individual cases + suspected cases and follow them. Working on a "line list": one line per case, with geography -- something some states or cities cluster by township, but rarely more granularly. Necessary for city-level modeling.
- Needed: Corona tests to confirm one person in a household is infected. Wanted: helpers who have done randomized trials and can work on stats and spreadsheet/case management.
Other drugs in testing or trials:
- 35 treatments in development [Geneng News]
- Roche's cobas, approved just today for use
- PittCoVacc, a prototype vaccine from the University of Pittsburgh, the first candidate to be published in a peer-reviewed study. Press Release Study in EBioMedicine
- CZI COVID task force -
- Official task force
- Database of research articles
- Open Source initiatives to help fight the pandemic — software, hardware and open data
Testing is in short supply. The US lags the most in this.
- WA: the UW virology lab is testing ~1000 samples a day and growing rapidly. Other unis should do the same.
- NY, MA, CA, TX, others will all need this.
- US standard: swab, package, and ship. Currently vials and swabs are back-ordered in the US by ~5wks.
- SG standard: blood draw + direct testing.
- RNA vs antibody tests: the latter tests exposure, including after the fact [signal of immunity]
see also visualizations
Maps: Commons, Plague.com (arcgis), ...
Visual essays: Act Today or People Will Die
COVID and people's Privacy
In the wake of COVID many small organizations (mom & pop business, doctor's offices, non-profits), including our own wmf, have recently started using technology such as w:Zoom Video Communications for conducting w:video conferencing. They use this technology to avoid face-to-face communication with clients, customers, or colleauges. Technology such as Zoom is advertised as "free software", but it costs money to produce, and companies that own such free software must make money in order to stay in business.
Smile of the day
with websites + other contact info: roster